Drug details:
Molecular formula: C₂₀H₃₉ClN₄O

Standard name: 4-(2-amino-1H-imidazol-5-yl)-N-tridecan-7-ylbutanamide;hydrochloride

Curated SMILES: CCCCCCC(CCCCCC)NC(=O)CCCC1=CN=C(N1)N.Cl

Evidence for compound's anti-virulence activity:

Acinetobacter
Related VFcategory: Biofilm
Target: Not determined
Drug effect: Inhibits biofilm formation.
Max phase: Preclinical (in vitro)
Publication:
Ballard TE, et al., 2008. Synthesis and antibiofilm activity of a second-generation reverse-amide oroidin library: a structure-activity relationship study. Chemistry 14(34):10745-61.

Pseudomonas
Related VFcategory: Biofilm
Target: Not determined
Drug effect: Inhibits biofilm formation.
Max phase: Preclinical (in vitro)
Publication:
Ballard TE, et al., 2008. Synthesis and antibiofilm activity of a second-generation reverse-amide oroidin library: a structure-activity relationship study. Chemistry 14(34):10745-61.